Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carnitine effect on plasma albumin level in hemodialysis patients
IRCT138804092106N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in end-stage kidney disease (ESKD), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Change in plasma albumin level. Started Oct 2008; status: completed.
02
Drugs
levocarnitine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT138804092106N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138804092106N1.